Drug intelligence / Profile preview

oxygen + nitrogen

Development stage
Unknown
Lead developer
Air Liquide
Modality
Small Molecules
Administration
Inhalation
01

Overview

oxygen + nitrogen is a medicinal gas mixture consisting of equal parts oxygen (50%) and nitrogen (50%). Developed by Air Liquide Santé International, this specific formulation was utilized as a control or placebo intervention in clinical trials, most notably the Phase 3 study NCT01146743. This trial evaluated the efficacy and safety of Kalinox (a 50/50 nitrous oxide/oxygen mixture) for pain management during care procedures in pediatric patients with burns. While oxygen is essential for cellular respiration and nitrogen serves as an inert carrier gas, the 50/50 ratio in this context is designed to mimic the delivery of the active analgesic gas mixture without providing the sedative or analgesic effects of nitrous oxide, thereby serving as a blinded comparator.

Other names
50% Oxygen/50% Nitrogen premixmedical air 50/50oxygen + nitrogen-Air Liquide Santé International-burns
02

Targets

COX7C (Cytochrome c oxidase subunit 7C, mitochondrial)

Beyond the preview

Go deeper on oxygen + nitrogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxygen + nitrogen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call